Company Overview and News

 
Chart of the day (century?): Price changes 1997 to 2017 - AEI

2018-02-19 aei.org
The global ‘educational-gender-equality paradox’: the more gender equality in a country, the fewer women in STEM
Upvote Downvote

1
Resources stocks lift as ASX grapples with low summer volumes

2018-01-03 theage.com.au
The Australian sharemarket rose for the first session in three, led by materials and energy stocks which were buoyed by a rally in commodity prices.
Upvote Downvote

1
Resources stocks lift as ASX grapples with low summer volumes

2018-01-03 smh.com.au
The Australian sharemarket rose for the first session in three, led by materials and energy stocks which were buoyed by a rally in commodity prices.
Upvote Downvote

3
Fastbrick in $35m placement

2017-11-22 businessnews.com.au
Fastbrick Robotics has raised $35 million through a share placement as the Perth-based technology company continues to develop its commercial prototype Hadrian X bricklaying robots.
Upvote Downvote

 
Fastbrick to build second prototype

2017-11-14 businessnews.com.au
Fastbrick Robotics has announced it will build a second of its commercial prototype Hadrian X in an effort to improve testing procedures.
Upvote Downvote

 
Calidus Resources, Fastbrick Robotics, AVZ Minerals sit on ASX Most Traded podium

2017-08-16 proactiveinvestors.com.au
The small-cap market is experiencing some frantic trading today, as companies deliver some positive news to the market.
Upvote Downvote

 
Fastbrick Robotics leads ASX % Gainers after deal with Saudi Arabia

2017-08-16 proactiveinvestors.com.au
Fastbrick Robotics Ltd's (ASX:FBR) shares have soared 54.3% to $0.27 in morning trade, following the company entering into a Memorandum of Understanding with Saudi Arabia.
Upvote Downvote

 
MARKET CLOSE: Mustang Resources, Race Oncology, Tanga Resources, HearMeOut

2017-07-17 proactiveinvestors.com.au
The ASX 200 resisted the pull higher from Asia as it eased 2.7 points to 5,762.40 with the rise of the Aussie dollar to a two-year high holding back the big export-led stocks.
Upvote Downvote

 
MIDDAY: Telstra, Volt Resources, HearMeOut, Tanga Resources, XJO

2017-07-17 proactiveinvestors.com.au
The ASX 200 was down 9.6 points at 5,775.5 at midday with large-cap Telstra Corp (ASX:TLS) falling 1.5%, continuing last week’s slide.
Upvote Downvote

 
Buddy Platform, Countplus, Kidman Resources, AVZ Minerals, 88 Energy - early movers

2017-07-14 proactiveinvestors.com.au
The ASX 200 built on Thursday’s impressive gains to open 9.2 points to the good at 5,746, defying predictions that it would in fact lose ground.
Upvote Downvote

 
Cardinal Resources, 88 Energy, Fastbrick Robotics, Slater & Gordon among the early movers

2017-07-13 proactiveinvestors.com.au
The ASX 200 (XJO) rebounded early on, tracking Wall Street, which was heartened by dovish comments by US Federal Reserve chair, Janet Yellen in testimony to Congress.
Upvote Downvote

 
Mark my words podcast

2017-07-07 businessnews.com.au
In this Business News podcast Mark Pownall and Mark Beyer discuss Paladin's collapse, Fastbrick Robotics, Peet and Perron Group, indigenous contracting and this year’s Total Shareholder Return survey.
Upvote Downvote

 
Fastbrick Robotics Ltd and Caterpillar teams up for robotic bricklaying

2017-07-05 proactiveinvestors.com.au
Fastbrick Robotics Ltd (ASX:FBR) has signed an agreement with Caterpillar Inc. (NYSE:CAT) regarding the development, manufacturing and sales of Fastbrick’s robotic bricklaying technology.
Upvote Downvote

2
Caterpillar to help globalise Perth's robot brickies

2017-07-03 businessnews.com.au
Robot bricklaying machines could be built and distributed worldwide by Caterpillar in the near future, after the technology’s Perth-based inventor, Fastbrick Robotics, signed a collaboration agreement with the global machinery manufacturer.
Upvote Downvote

 
Fastbrick signs a deal with Caterpillar to develop bricklaying robots

2017-07-03 theage.com.au
Investors poured into small-cap robotics company, Fastbrick Robotics, on Monday after the company struck a deal with global construction manufacturer Caterpillar.
Upvote Downvote

Related Articles

GNCA: Genocea Biosciences Analysis and Research Report

11h - Asif

Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...

AMZN: Amazon.com, Inc Analysis and Research Report

12h - Asif

Overview Amazon.com opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...